Who Paid My Doc
Neuroblate
Device NeuroBlate
General payments
$2,059,350
Research payments
$1,380,459
Through program year 2025, $2,059,350 in general payments and $1,380,459 in research payments were reported against Neuroblate (NeuroBlate).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $216,102 | 603 |
| 2025 | Research | $247,239 | 84 |
| 2024 | General | $197,464 | 433 |
| 2024 | Research | $278,356 | 73 |
| 2023 | General | $313,433 | 500 |
| 2023 | Research | $854,864 | 268 |
| 2022 | General | $439,494 | 447 |
| 2020 | General | $428,347 | 128 |
| 2019 | General | $464,510 | 933 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 25 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 33 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
3,044 general · 425 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.